CTAT Conjugation for Diagnostics & Antibody Drug Conjugates (ADC’s)
The CTAT Enzymatic Antibody Drug Conjugation Technology -Benefits for Diagnostic Applications and ADC’s for Oncology. A EUCODIS Bioscience Case Study
Read moreThe CTAT Enzymatic Antibody Drug Conjugation Technology -Benefits for Diagnostic Applications and ADC’s for Oncology. A EUCODIS Bioscience Case Study
Read moreThe main protease (Mpro) is a key enzyme of SARS-CoV-2 and is required for viral replication and transcription. A Biosynth
Read moreBiosynth, which acquired EUCODIS Bioscience in 2022, has taken over the helm in developing new microbial enzymes for generating eco-friendly
Read moreHiDi® Taq DNA polymerase has been engineered for use in mutation detections especially via allele-specific PCR (asPCR), also known as
Read moreEUCODIS Bioscience provides highly efficient custom recombinant protein services based on its vast experience in expression systems, downstream processing and
Read moreEUCODIS Bioscience manufactures catalase for inactivation of hydrogen peroxide (H2O2) in environmental monitoring of sterilization in production facilities, clean rooms,
Read moreEUCODIS Bioscience offers a broad range of microbial lipases for the pharmaceutical industry. EUCODIS has a collection of over 70
Read moreFollowing the enormous success of Candida antarctica lipase B (CalB) variants introduced in 2017 by EUCODIS Bioscience, now operating under
Read moreEctica Technologies provides custom development and manufacturing of specialty chemicals for drug discovery and development in the pharmaceutical, biotechnology and
Read more